Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.954    -0.006 (-0.63%)
Bid:
0.954
Ask:
0.956
Spread: 0.002 (0.21%)
Market Cap: $1.07b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Holding(s) in Company

12 Apr 2021 11:00

RNS Number : 1386V
BioPharma Credit PLC
12 April 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDGKMY29

Issuer Name

BIOPHARMA CREDIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Newton Investment Management Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Is the shareholder the same as the person subject to the notification obligation, above?

Yes

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2021

6. Date on which Issuer notified

09-Apr-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.926571

0.000000

9.926571

136378417

Position of previous notification (if applicable)

10.02

N/A

10.02

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

CLASS/TYPE OF SHARES ISIN CODE(IF POSSIBLE)

NUMBER OF DIRECT VOTING RIGHTS (DTR5.1)

NUMBER OF INDIRECT VOTING RIGHTS (DTR5.2.1)

% OF DIRECT VOTING RIGHTS (DTR5.1)

% OF INDIRECT VOTING RIGHTS (DTR5.2.1)

GB00BDGKMY29

136378417

9.926571

Sub Total 8.A

136378417

9.926571%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

NUMBER OF VOTING RIGHTS THAT MAY BE ACQUIRED IF THE INSTRUMENT IS EXERCISED/CONVERTED

% OF VOTING RIGHTS

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

PHYSICAL OR CASH SETTLEMENT

NUMBER OF VOTING RIGHTS

% OF VOTING RIGHTS

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate Controlling Person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Is there proxy voting?

No

Name of the proxy holder

 

The number and % of voting rights held

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

09-Apr-2021

13. Place Of Completion

Uniondale, New York

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUUSKRAWUSARR
Date   Source Headline
22nd Sep 20257:00 amRNSHalf-year Report
18th Sep 20255:15 pmRNSDividend Declaration
3rd Sep 202512:21 pmRNSNEW INVESTMENT OF UP TO US$62.5 MILLION
1st Sep 20252:26 pmRNSTotal Voting Rights
26th Aug 20257:00 amRNSNotice of Half Year Results
22nd Aug 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Aug 202512:07 pmRNSTransaction in Own Shares - Correction
20th Aug 20256:16 pmRNSTransaction in Own Shares
12th Aug 20255:39 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSAppointment of New Director
21st Jul 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Jul 20254:23 pmRNSHolding(s) in Company
1st Jul 202512:02 pmRNSSTATEMENT RE BIOCRYST
24th Jun 20253:39 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Jun 20257:00 amRNSDividend Declaration
10th Jun 202510:56 amRNSDirector Declaration
9th Jun 20254:37 pmRNSResult of AGM
22nd May 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd May 20257:00 amRNSUPDATE ON INVESTMENT PORTFOLIO
12th May 20253:36 pmRNSDirector/PDMR Shareholding
9th May 20254:34 pmRNSNotice of Annual General Meeting
6th May 20257:00 amRNSUPDATE ON INVESTMENTS
1st May 202512:36 pmRNSTotal Voting Rights
28th Apr 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Apr 20256:15 pmRNSTransaction in Own Shares
8th Apr 20256:15 pmRNSTransaction in Own Shares
7th Apr 20256:15 pmRNSTransaction in Own Shares
4th Apr 20256:15 pmRNSTransaction in Own Shares
3rd Apr 20256:15 pmRNSTransaction in Own Shares
2nd Apr 20256:15 pmRNSTransaction in Own Shares
2nd Apr 20255:21 pmRNSHolding(s) in Company
2nd Apr 20252:35 pmRNSBIOGEN SETTLEMENT
1st Apr 20256:15 pmRNSTransaction in Own Shares
1st Apr 202511:56 amRNSTotal Voting Rights
31st Mar 20256:15 pmRNSTransaction in Own Shares
27th Mar 20256:15 pmRNSTransaction in Own Shares
26th Mar 20256:15 pmRNSTransaction in Own Shares
25th Mar 20256:15 pmRNSTransaction in Own Shares
25th Mar 20257:01 amRNSDividend Declaration
25th Mar 20257:00 amRNSAnnual Financial Report
24th Mar 20256:15 pmRNSTransaction in Own Shares
21st Mar 20256:15 pmRNSTransaction in Own Shares
21st Mar 20255:19 pmRNSHolding(s) in Company
21st Mar 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Mar 20257:00 amRNSSTATEMENT RE OPTINOSE, INC.
20th Mar 20256:15 pmRNSTransaction in Own Shares
20th Mar 20257:00 amRNSAppointment of Joint Corporate Broker
19th Mar 20256:15 pmRNSTransaction in Own Shares
18th Mar 20256:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.